Despite regulation changes in the Chinese healthcare industry, we think CSPC is well-positioned to maintain relatively strong revenue growth. First, generic drugs normally face the most severe price ...

A new study out of Spain has ignited discussions around the long-term effects of repeated COVID-19 vaccinations, raising questions about vaccine efficacy and safety that many in the healthcare ...

Why not all African countries should venture into vaccine business ANALYSIS | The African Union has embarked on one of its ...

A research team at Korea University's Vaccine Innovation Center (Center Director Jung Hee-jin) announced promising results in research on mRNA vaccine development to prevent hantavirus infections.In a ...

Werner held roles at Bristol Myers Squibb, AstraZeneca and Novartis before landing at Alltrna, where she works to develop tRNA-based treatments for a range of diseases.

AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published its 2024 Annual Results announcement on March 30, 2025, the company recorded revenues of RMB 1,285 million in 2024, an ...

With improved market conditions, innovative breakthroughs, and more investor interest, the biotechnology industry is gaining new traction.

We recently published a list of Jim Cramer Discussed These 9 Stocks Recently. In this article, we are going to take a look at ...

U.S. health agency leadership and policymakers seem intent on undermining trust in mRNA, the technology that saved millions of lives during the COVID pandemic and has shown promise in addressing a ran ...

Novo Nordisk may miss sales expectations; federal judge fines Johnson & Johnson $1.64 billion in marketing case; CureVac mRNA ...

A top vaccine advisor at the FDA was forced to resign on Friday. In his resignation letter, Dr. Peter Marks, wrote "truth and ...